₹13.27 for Q4 which increased by 51.29% Y-o-Y.Torrent Pharmaceuticals has delivered -0.26% return in the last 1 week, 27.83% return in the last 6 months, and 16.8% YTD return.Currently, Torrent Pharmaceuticals has a market cap of ₹91139.98 Cr and 52wk high/low of ₹2782.85 & ₹1683.1 respectively.As of 25 May, 2024, out of 26 analysts covering the company, 2 analysts have given Sell rating, 4 analysts have given Hold rating, 12 analysts have given Buy rating, and 8 analysts have given Strong Buy rating.The consensus recommendation as of 25 May, 2024, was to Buy.FAQsQuestion : What is the Q4 profit/Loss as per company?Ans : ₹449CrQuestion : What is Q4 revenue?Ans : ₹2745CrStay updated on quarterly results with our results calendarMilestone Alert!
Livemint tops charts as the fastest growing news website in the world